Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?

European Journal of Pain (United Kingdom)

Volumn 17, Issue 9, 2013, Pages 1299-1306

  Keszthelyi, Daniel ^a,b   Troost, F J ^a,b   Jonkers, D M ^a,b   Helyes, Z ^c   Hamer, H M ^a,b   Ludidi, S ^b   Vanhoutvin, S ^a,b   Venema, K ^a,d   Dekker, J ^a,e   Szolcsanyi J ^c   Masclee, A A ^a,c  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PÉCS   (Hungary)

^d TNO   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; COLITIS, ULCERATIVE; COLON, SIGMOID; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; SOMATOSTATIN; SUBSTANCE P; TRPV CATION CHANNELS;

EID: 84882350278     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00309.x     Document Type: Article

References (31)

1. Akbar, A., Yiangou, Y., Facer, P., Brydon, W.G., Walters, J.R., Anand, P., Ghosh, S. (2010). Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 59, 767-774.
2. Akbar, A., Yiangou, Y., Facer, P., Walters, J.R., Anand, P., Ghosh, S. (2008). Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57, 923-929.
3. van Bergeijk, J.D., Wilson, J.H., Nielsen, O.H., von Tirpitz, C., Karvonen, A.L., Lygren, I., Radler, A., Waldum, H.L., Mulder, C.J., Friis, S., Tefera, S., Hoogkamer, J.F. (2002). Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1). Eur J Gastroenterol Hepatol 14, 243-248.
4. Bernstein, C.N., Robert, M.E., Eysselein, V.E. (1993). Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 88, 908-913.
5. Bueno, L., Fioramonti, J., Garcia-Villar, R. (2000). Pathobiology of visceral pain: Molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: A source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 278, G670-G676.
6. Carlton, S.M., Zhou, S., Du, J., Hargett, G.L., Ji, G., Coggeshall, R.E. (2004). Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1) ion channel. Pain 110, 616-627.
7. Geppetti, P., Trevisani, M. (2004). Activation and sensitisation of the vanilloid receptor: Role in gastrointestinal inflammation and function. Br J Pharmacol 141, 1313-1320.
8. Goode, T., O'Connell, J., Anton, P., Wong, H., Reeve, J., O'Sullivan, G.C., Collins, J.K., Shanahan, F. (2000). Neurokinin-1 receptor expression in inflammatory bowel disease: Molecular quantitation and localisation. Gut 47, 387-396.
9. Green, P.G., Basbaum, A.I., Levine, J.D. (1992). Sensory neuropeptide interactions in the production of plasma extravasation in the rat. Neuroscience 50, 745-749.
10. Hamer, H.M., Jonkers, D.M., Vanhoutvin, S.A., Troost, F.J., Rijkers, G., de Bruine, A., Bast, A., Venema, K., Brummer, R.J. (2010). Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 29, 738-744.
11. van der Heide, H., van den Brandt-Gradel, V., Tytgat, G.N., Endert, E., Wiltink, E.H., Schipper, M.E., Dekker, W. (1988). Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol 10, 169-172.
12. Holzer, P. (2011). Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131, 142-170.
13. Isgar, B., Harman, M., Kaye, M.D., Whorwell, P.J. (1983). Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 24, 190-192.
14. Keranen, U., Kiviluoto, T., Jarvinen, H., Back, N., Kivilaakso, E., Soinila, S. (1995). Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci 40, 2250-2258.
15. Kerckhoffs, A.P., Ter Linde, J.J., Akkermans, L.M., Samsom, M. (2012). SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients irrespective of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol 302, G1053-G1060.
16. Keszthelyi, D., Troost, F.J., Simren, M., Ludidi, S., Kruimel, J.W., Conchillo, J.M., Masclee, A.A. (2012). Revisiting concepts of visceral nociception in irritable bowel syndrome. Eur J Pain 16, 1444-1454.
17. Nemeth, J., Helyes, Z., Gorcs, T., Gardi, J., Pinter, E., Szolcsanyi, J. (1996). Development of somatostatin radioimmunoassay for the measurement of plasma and tissue contents of hormone. Acta Physiol Hung 84, 313-315.
18. Nemeth, J., Oroszi, G., Than, M., Helyes, Z.S., Pinter, E., Farkas, B., Szolcsanyi, J. (1999). Substance P radioimmunoassay for quantitative characterization of sensory neurotransmitter release. Neurobiology (Bp) 7, 437-444.
19. Patterson, L.M., Zheng, H., Ward, S.M., Berthoud, H.R. (2003). Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res 311, 277-287.
20. Penman, E., Wass, J.A., Butler, M.G., Penny, E.S., Price, J., Wu, P., Rees, L.H. (1983). Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Regul Pept 7, 53-65.
21. Pinter, E., Helyes, Z., Szolcsanyi, J. (2006). Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther 112, 440-456.
22. Schicho, R., Florian, W., Liebmann, I., Holzer, P., Lippe, I.T. (2004). Increased expression of TRPV1 receptor in dorsal root ganglia by acid insult of the rat gastric mucosa. Eur J Neurosci 19, 1811-1818.
23. Simren, M., Axelsson, J., Gillberg, R., Abrahamsson, H., Svedlund, J., Bjornsson, E.S. (2002). Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97, 389-396.
24. Szallasi, A., Nilsson, S., Farkas-Szallasi, T., Blumberg, P.M., Hokfelt, T., Lundberg, J.M. (1995). Vanilloid (capsaicin) receptors in the rat: Distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 703, 175-183.
25. Teitelbaum, D.H., Del Valle, J., Reyas, B., Post, L., Gupta, A., Mosely, R.L., Merion, R. (1996). Intestinal intraepithelial lymphocytes influence the production of somatostatin. Surgery 120, 227-232; discussion 232-223.
26. Tohda, C., Sasaki, M., Konemura, T., Sasamura, T., Itoh, M., Kuraishi, Y. (2001). Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 76, 1628-1635.
27. Van Assche, G., Ferrante, M., Vermeire, S., Noman, M., Rans, K., Van Der Biest, L., Penninckx, F., Wolthuis, A., Rutgeerts, P., D'Hoore, A. (2012). Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: A placebo-controlled crossover study. Colorectal Dis 14, e181-e186.
28. Ward, S.M., Bayguinov, J., Won, K.J., Grundy, D., Berthoud, H.R. (2003). Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 465, 121-135.
29. Watanabe, T., Kubota, Y., Muto, T. (1997). Substance P containing nerve fibers in rectal mucosa of ulcerative colitis. Dis Colon Rectum 40, 718-725.
30. Yamamoto, H., Morise, K., Kusugami, K., Furusawa, A., Konagaya, T., Nishio, Y., Kaneko, H., Uchida, K., Nagai, H., Mitsuma, T., Nagura, H. (1996). Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease. J Gastroenterol 31, 525-532.
31. Yiangou, Y., Facer, P., Dyer, N.H., Chan, C.L., Knowles, C., Williams, N.S., Anand, P. (2001). Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 357, 1338-1339.